Global Nanopore Sequencing Market – Set to Witness Exponential Growth

BRUSSELS - Oct. 6, 2022 - PRLog -- The Global Nanopore Sequencing Market valued at $200 million (2021) is set to witness a significant growth rate of 26% in the next 5 years. Some of the main factors propelling the Global Nanopore Sequencing Market is the advantages of nanopore sequencing such as high throughput & ultra-long reads, technological developments in nanopore technologies, growing prevalence of infectious diseases, and rising investments in R&D.

Advantages of nanopore sequencing technology fuels the Nanopore Sequencing Market Demand

Over the years, there has been a substantial growth in the acceptance of nanopore sequencing for research as well as clinical applications because of significant advantages of nanopores such as label-free & ultralong reads and high throughput.

Some of the main advantages boosting its demand are:

• Long-read sequencing: The ability to produce ultra-long reads of over 2 Mb is a major advantage of nanopore sequencing. Longer read lengths are more likely to cover full regions of repeated sequence and structural variation, allowing for a more comprehensive understanding of genetic variants and the reconstruction of complex genomes
• Targeted sequencing: For nanopore sequencing, a variety of targeted sequencing approaches, such as targeted panels and whole exome enrichment, are available, leveraging both PCR- and hybrid capture-based targeted enrichment strategies
• Rapid results: Unlike traditional sequencing approaches, which need analysis after sequencing is completed, nanopore sequencing allows for early insights to be gained as soon as the sequencing process begins
• Low cost of sequencer: High-end sequencers from Illumina and PacBio are priced over $950k and $450k respectively which are too expensive as compared to the GridION nanopore-based sequencer offered by Oxford Nanopore Technologies at $49k
• Increasing clinical applications: Nanopore sequencing is widely used for pathogen analysis such as outbreak surveillance of infectious diseases such as tuberculosis, Ebola, Zika, dengue fever, and Covid19, among others. Nanopore sequencing is also widely used by researchers and clinicians for cancer genomics and genetic disease diagnosis.

Explore Premium Report on Nanopore Sequencing Market @ https://meditechinsights.com/nanopore-sequencing-market/

Competitive Landscape Analysis of Nanopore Sequencing Market

The global nanopore sequencing market is marked by the presence of key players such as Oxford Nanopore Technologies (UK), Stratos Genomics, a Roche company (US), BaseClear B.V. (Netherlands), CD Genomics (US), and others.